MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function
Open Access
- 6 February 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (8), 3125-3130
- https://doi.org/10.1073/pnas.1113793109
Abstract
Schizophrenia is characterized by affective, cognitive, neuromorphological, and molecular abnormalities that may have a neurodevelopmental origin. MicroRNAs (miRNAs) are small noncoding RNA sequences critical to neurodevelopment and adult neuronal processes by coordinating the activity of multiple genes within biological networks. We examined the expression of 854 miRNAs in prefrontal cortical tissue from 100 control, schizophrenic, and bipolar subjects. The cyclic AMP-responsive element binding- and NMDA-regulated microRNA miR-132 was significantly down-regulated in both the schizophrenic discovery cohort and a second, independent set of schizophrenic subjects. Analysis of miR-132 target gene expression in schizophrenia gene-expression microarrays identified 26 genes up-regulated in schizophrenia subjects. Consistent with NMDA-mediated hypofunction observed in schizophrenic subjects, administration of an NMDA antagonist to adult mice results in miR-132 down-regulation in the prefrontal cortex. Furthermore, miR-132 expression in the murine prefrontal cortex exhibits significant developmental regulation and overlaps with critical neurodevelopmental processes during adolescence. Adult prefrontal expression of miR-132 can be down-regulated by pharmacologic inhibition of NMDA receptor signaling during a brief postnatal period. Several key genes, including DNMT3A, GATA2, and DPYSL3, are regulated by miR-132 and exhibited altered expression either during normal neurodevelopment or in tissue from adult schizophrenic subjects. Our data suggest miR-132 dysregulation and subsequent abnormal expression of miR-132 target genes contribute to the neurodevelopmental and neuromorphological pathologies present in schizophrenia.This publication has 44 references indexed in Scilit:
- An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAPProceedings of the National Academy of Sciences of the United States of America, 2008
- Neuregulin 1 in neural development, synaptic plasticity and schizophreniaNature Reviews Neuroscience, 2008
- Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse modelNature Genetics, 2008
- PLA2 signaling is involved in calpain-mediated degradation of synaptic dihydropyrimidinase-like 3 protein in response to NMDA excitotoxicityNeuroscience Letters, 2008
- Dysregulation of miRNA 181b in the temporal cortex in schizophreniaHuman Molecular Genetics, 2008
- The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive ImpairmentsAmerican Journal of Psychiatry, 2007
- MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed PairingMolecular Cell, 2007
- Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesisMethods and Findings in Experimental and Clinical Pharmacology, 2007
- microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorderGenome Biology, 2007
- Dopamine Modulation of Prefrontal Cortical Interneurons Changes during AdolescenceCerebral Cortex, 2006